Ultrapotent compound may help treat C. diff, reduce recurrence

Clostridioides difficile, or C. diff, is the leading cause of health care-associated infection in the U.S. Only two antibiotics, vancomycin and fidaxomicin, are FDA-approved for the treatment of C. diff, but even these therapies suffer from high treatment failure and...

Tampa General Hospital, Philips announce partnership

The seven-year agreement will upgrade technology throughout the hospital and improve efficiency Tampa General Hospital (TGH) and Royal Philips announced they are creating a long-term strategic partnership designed to keep Tampa General Hospital at the forefront of...

PENTAX Medical Launches Bronchoscopes, Video Processor in U.S.

PENTAX Medical has launched the EB-J10 Series Bronchoscopes in the U.S., with FDA 510(k) clearance, along with a new DEFINA Video Processor. As the newest HD solution in pulmonology, the EB-J10 Series Bronchoscopes offer crisp, HD visualization of the bronchus, along...

Nautilus Medical Launches All-in-One DICOM Surgical Recorder

Nautilus Medical Technologies has announced an advanced all-in-one surgery recorder, named TeleRay Record, for use with any endoscope, headset, c-arm, vascular, ultrasound, c-arms and more. Users will be able to store up to 150 hours of HD medical videos form a...

Exactech Appoints New Chief Financial Officer

Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, has announced Kerem Bolukbasi as its new chief financial officer (CFO). Bolukbasi joins Exactech from TPG Capital where he served as an operations executive and was responsible for providing interim executive leadership and operational support to management teams and boards of directors for the firm’s portfolio companies.

“It’s a pleasure to officially welcome Kerem to the Exactech team where he will undoubtedly make a great impact on our success,” said Exactech Chief Executive Officer Darin Johnson. “Kerem has already contributed significantly to supporting our business continuity efforts throughout the COVID-19 pandemic. We look forward to leveraging his experience in leading global financial and operational functions across large and diverse companies to position Exactech for sustainable, long-term growth and enhanced valuation.”

According to Bolukbasi, “Exactech is differentiated in the orthopaedics industry with an exciting and aggressive pipeline of new technologies and solutions for surgeons and patients across the globe. I am thrilled to join the company at this exciting and pivotal time.”

Bolukbasi’s roles with TPG Capital have included interim CFO and COO for Vice Media, Transplace, McAfee, Fleetpride and Adare Pharmaceuticals. Prior to this, he served as CFO for the GE Gas Engines and Engineering Division of GE Energy. Bolukbasi will lead Exactech’s global financial operations, finance teams and activities. He will report directly to Johnson and will succeed Jody Phillips, who has served as Exactech’s CFO for the past 27 years.

“Since joining the company in 1993, Jody has been a respected leader and mentor to many Exactech employees,” Johnson said. “He was instrumental in the company’s growth from the initial public offering in 1996, through our go-private transition with TPG Capital in 2018 and beyond. I’d like to thank Jody both personally and on behalf of Exactech for his dedicated service and contributions.”



Submit a Comment

Your email address will not be published. Required fields are marked *